EP3445368
COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.4.2017:
17.7.2024:
17786774.4
:
20.4.2037
:
COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS
21.4.2017
17.7.2024
:
Astrocyte Pharmaceuticals, Inc.:
245 First Street Suite 1800, Cambridge, Massachusetts 02142, US
:
Board of Regents, The University of Texas System:
210 West 7th Street, Austin, TX 78701, US
:
The U.S.A. as represented by the Secretary, Department of Health and Human Services:
National Institutes of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US
:
KORINEK, William S.:
Mystic Connecticut 06355, US
:
LECHLEITER, James D.:
San Antonio Texas 78213, US
:
LISTON, Theodore E.:
Stonington Connecticut 06378, US
:
JACOBSON, Kenneth A.:
Silver Spring Maryland 20902, US
:
201662325860 P:
21.4.2016:
US
:
US2017028996:
21.4.2017
:
A61K 31/52, A61K 31/7076, A61K 31/519, A61P 25/00, A61P 9/00